Login
$CGEM
$9.51 -$0.77 (7.49%) Live

Company Executives

Officer Age In this role 2025 pay Source
Nadim Ahmed Also a director
President and CEO
Title from the Form 4 dated Feb 24, 2026
58 Not stated $5,100,006
Mary Kay Fenton
Chief Financial Officer
62 Since 2024
2 years
$2,078,837
Jeffrey Jones, M.D.
Chief Medical Officer
55 Since 2022
4 years
$2,221,578
Jennifer Michaelson, Ph.D.
Chief Scientific Officer
59 Since 2023
3 years
Not reported
Corinne Savill, Ph.D.
Chief Business Officer
66 Since 2017
9 years
Not reported
Jacquelyn Sumer, Esq.
Chief Legal Officer
Title from the Form 4 dated Jun 30, 2026
48 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
3.7 years
from year joined
CEO also chairs the board
No
Anthony Rosenberg
Director Age On board Independent Committees Other public boards 2025 pay Source
Anthony Rosenberg
72 2017
9 years
Independent
Audit Committee
argenx SE, Oculis Holding AG $306,329
Nadim Ahmed
58 2021
5 years
Not independent None stated Disc Medicine, Inc. Paid as CEO
Stephen Webster
65 2020
6 years
Independent
Audit Committee · Chair Compensation Committee
NextCure, Inc. $283,186
Mittie Doyle, M.D., FACR
61 2025
1 year
Independent
Nominating and Corporate Governance Committee
None stated $376,928
David Meek
62 2024
2 years
Independent
Audit Committee
Swedish Orphan Biovitrum AB, uniQure N.V. $268,639
Andrew Allen, M.D., Ph.D.
59 2025
1 year
Independent
Compensation Committee
None stated $377,326
Mary Thistle
66 2024
2 years
Independent
Nominating and Corporate Governance Committee
Q32 Bio Inc., Entrada Therapeutics, Inc., Aktis Oncology, Inc. $49,781

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support